| Basics |
Cerus Corporation
Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.
|
| IPO Date: |
January 31, 1997 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$254.96M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.11 | 2.74%
|
| Avg Daily Range (30 D): |
$0.03 | 2.53%
|
| Avg Daily Range (90 D): |
$0.04 | 2.91%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.74M |
| Avg Daily Volume (30 D): |
1M |
| Avg Daily Volume (90 D): |
.98M |
| Trade Size |
| Avg Trade Size (Sh.): |
177 |
| Avg Trade Size (Sh.) (30 D): |
196 |
| Avg Trade Size (Sh.) (90 D): |
202 |
| Institutional Trades |
| Total Inst.Trades: |
950 |
| Avg Inst. Trade: |
$1.27M |
| Avg Inst. Trade (30 D): |
$.75M |
| Avg Inst. Trade (90 D): |
$1.1M |
| Avg Inst. Trade Volume: |
.24M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.26M |
| Avg Closing Trade (30 D): |
$1.75M |
| Avg Closing Trade (90 D): |
$1.14M |
| Avg Closing Volume: |
226.76K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.1
|
$-.03
|
$-.04
|
|
Diluted EPS
|
$-.1
|
$-.03
|
$-.04
|
|
Revenue
|
$ 212.61M
|
$ 36.66M
|
$ 31.04M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -18.93M
|
$ -5.72M
|
$ -7.72M
|
|
Operating Income / Loss
|
$ -11.69M
|
$ -3.42M
|
$ -5.85M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 3.02M
|
$ -3.45M
|
$ -.78M
|
|
PE Ratio
|
|
|
|
|
|
|
